Literature DB >> 22801424

Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan.

Naoki Nakagawa1, Hiroshi Manya, Tatsushi Toda, Tamao Endo, Shogo Oka.   

Abstract

Retinoic acid (RA) is a well established anti-tumor agent inducing differentiation in various cancer cells. Recently, a robust up-regulation of human natural killer-1 sulfotransferase (HNK-1ST) was found in several subsets of melanoma cells during RA-mediated differentiation. However, the molecular mechanism underlying the tumor suppression mediated by HNK-1ST remains unclear. Here, we show that HNK-1ST changed the glycosylation state and reduced the ligand binding activity of α-dystroglycan (α-DG) in RA-treated S91 melanoma cells, which contributed to an attenuation of cell migration. Knockdown of HNK-1ST restored the glycosylation of α-DG and the migration of RA-treated S91 cells, indicating that HNK-1ST functions through glycans on α-DG. Using CHO-K1 cells, we provide direct evidence that HNK-1ST but not other homologous sulfotransferases (C4ST1 and GalNAc4ST1) suppresses the glycosylation of α-DG. The activity-abolished mutant of HNK-1ST did not show the α-DG-modulating function, indicating that the sulfotransferase activity of HNK-1ST is essential. Finally, the HNK-1ST-dependent incorporation of [(35)S]sulfate groups was detected on α-DG. These findings suggest a novel role for HNK-1ST as a tumor suppressor controlling the functional glycans on α-DG and the importance of sulfate transfer in the glycosylation of α-DG.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801424      PMCID: PMC3436325          DOI: 10.1074/jbc.M112.363036

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function.

Authors:  Daniel E Michele; Kevin P Campbell
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

2.  Cloning and functional expression of a novel glucuronyltransferase involved in the biosynthesis of the carbohydrate epitope HNK-1.

Authors:  K Terayama; S Oka; T Seiki; Y Miki; A Nakamura; Y Kozutsumi; K Takio; T Kawasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 3.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

4.  Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy.

Authors:  D K Chou; A A Ilyas; J E Evans; C Costello; R H Quarles; F B Jungalwala
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

5.  Glycomic analyses of mouse models of congenital muscular dystrophy.

Authors:  Stephanie H Stalnaker; Kazuhiro Aoki; Jae-Min Lim; Mindy Porterfield; Mian Liu; Jakob S Satz; Sean Buskirk; Yufang Xiong; Peng Zhang; Kevin P Campbell; Huaiyu Hu; David Live; Michael Tiemeyer; Lance Wells
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

6.  Molecular cloning and expression of chondroitin 4-sulfotransferase.

Authors:  S Yamauchi; S Mita; T Matsubara; M Fukuta; H Habuchi; K Kimata; O Habuchi
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

7.  Structure and function of HNK-1 sulfotransferase. Identification of donor and acceptor binding sites by site-directed mutagenesis.

Authors:  E Ong; J C Yeh; Y Ding; O Hindsgaul; L C Pedersen; M Negishi; M Fukuda
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

8.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.

Authors:  Cheryl Longman; Martin Brockington; Silvia Torelli; Cecilia Jimenez-Mallebrera; Colin Kennedy; Nofal Khalil; Lucy Feng; Ravindra K Saran; Thomas Voit; Luciano Merlini; Caroline A Sewry; Susan C Brown; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

9.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.

Authors:  Daniel Beltrán-Valero de Bernabé; Kei-Ichiro Inamori; Takako Yoshida-Moriguchi; Christine J Weydert; Hollie A Harper; Tobias Willer; Michael D Henry; Kevin P Campbell
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

View more
  11 in total

1.  Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy.

Authors:  Hirokazu Yagi; Chu-Wei Kuo; Takayuki Obayashi; Satoshi Ninagawa; Kay-Hooi Khoo; Koichi Kato
Journal:  Mol Cell Proteomics       Date:  2016-09-06       Impact factor: 5.911

Review 2.  Recent advancements in understanding mammalian O-mannosylation.

Authors:  M Osman Sheikh; Stephanie M Halmo; Lance Wells
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

Review 3.  Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy.

Authors:  David Live; Lance Wells; Geert-Jan Boons
Journal:  Chembiochem       Date:  2013-11-07       Impact factor: 3.164

4.  Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function.

Authors:  M Osman Sheikh; Chantelle J Capicciotti; Lin Liu; Jeremy Praissman; Dahai Ding; Daniel G Mead; Melinda A Brindley; Tobias Willer; Kevin P Campbell; Kelley W Moremen; Lance Wells; Geert-Jan Boons
Journal:  Nat Commun       Date:  2022-06-24       Impact factor: 17.694

5.  HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan.

Authors:  M Osman Sheikh; David Venzke; Mary E Anderson; Takako Yoshida-Moriguchi; John N Glushka; Alison V Nairn; Melina Galizzi; Kelley W Moremen; Kevin P Campbell; Lance Wells
Journal:  Glycobiology       Date:  2020-09-28       Impact factor: 4.313

Review 6.  Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.

Authors:  Takako Yoshida-Moriguchi; Kevin P Campbell
Journal:  Glycobiology       Date:  2015-04-16       Impact factor: 4.313

7.  AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.

Authors:  Hirokazu Yagi; Naoki Nakagawa; Takuya Saito; Hiroshi Kiyonari; Takaya Abe; Tatsushi Toda; Sz-Wei Wu; Kay-Hooi Khoo; Shogo Oka; Koichi Kato
Journal:  Sci Rep       Date:  2013-11-21       Impact factor: 4.379

Review 8.  Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates.

Authors:  Jeremy L Praissman; Lance Wells
Journal:  Biochemistry       Date:  2014-05-07       Impact factor: 3.162

9.  Highlights of glycosylation and adhesion related genes involved in myogenesis.

Authors:  Vincent Grassot; Anne Da Silva; James Saliba; Abderrahman Maftah; Fabrice Dupuy; Jean-Michel Petit
Journal:  BMC Genomics       Date:  2014-07-22       Impact factor: 3.969

Review 10.  Aggrecan, the Primary Weight-Bearing Cartilage Proteoglycan, Has Context-Dependent, Cell-Directive Properties in Embryonic Development and Neurogenesis: Aggrecan Glycan Side Chain Modifications Convey Interactive Biodiversity.

Authors:  Anthony J Hayes; James Melrose
Journal:  Biomolecules       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.